MarketCapTrends
XENE
Xenon Pharmaceuticals Inc. (XENE)
NASDAQ

Xenon Pharmaceuticals Inc. Cash on Hand 2012–2025

Xenon Pharmaceuticals Inc. annual/quarterly cash on hand history from 2013 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Xenon Pharmaceuticals Inc. cash on hand for the quarter ending December 31, 2025 were 199.2M, a 39.56% increase year-over-year.
  • Xenon Pharmaceuticals Inc. cash on hand for 2025 were 199.2M, a 39.56% increase from 2024.
  • Xenon Pharmaceuticals Inc. cash on hand for 2024 were 142.7M, a 3.99% decrease from 2023.
  • Xenon Pharmaceuticals Inc. cash on hand for 2023 were 148.6M, a 159.67% increase from 2022.
  • Xenon Pharmaceuticals Inc. cash on hand for 2022 were 57.2M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Xenon Pharmaceuticals Inc. Annual Cash on Hand (Millions of US $)
2025$199
2024$143
2023$149
2022$57
2021$176
2020$45
2019$25
2017$20
2016$17
2015$59
2014$72
2013$38
Xenon Pharmaceuticals Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$199
2024-12-31$143
2023-12-31$149
2022-12-31$57
2021-12-31$176
2020-12-31$45
2019-12-31$25
2017-12-31$20
2016-12-31$17
2015-12-31$59
2014-12-31$72
2013-12-31$38

Xenon Pharmaceuticals Inc. Cash on Hand — FAQ

Xenon Pharmaceuticals Inc. (XENE) cash on hand over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see XENE's cash on hand history?

The chart and table above show Xenon Pharmaceuticals Inc.'s cash on hand by year and by quarter, including the growth rate.